Preparation of anti-human seminoprotein specificity single chain antibody and application method thereof
A single-chain antibody and seminal plasma protein technology, applied in the field of bioengineering, can solve the problems of large molecular weight, long preparation cycle, and difficulty in passing through cancer cell membranes, etc., and achieve the effect of increased sensitivity and small size
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0030] According to the above technical scheme, the anti-γ seminal plasma protein single-chain antibody was prepared by combining the polymerase chain reaction 1 and the polymerase chain reaction 2 with the preparation reaction 3, and the specific steps were as follows:
[0031] The first step is to design primers and use polymerase chain reaction technology to obtain anti-human γ-seminal plasma protein single-chain antibody gene fragments
[0032]In order to make the prepared antibodies easier to purify and penetrate the cell membrane, the primers were designed with a histidine tail and a transmembrane peptide KTAT (acid-resistant-threonine-alanine-threonine) at the amino terminus. The upstream primer is: 5'-CGCTTAATTAAA CAG ACC AAG GCG ACC CAT ATG ACC CAG GTC CAA CTG CAG-3', the downstream primer is: 5'-TTAGTTAGTTACCGGATCCC ACG TTT GAT CTC CAG-3', the total length is 783bp (base pairs).
[0033] Use polymerase chain reaction 1 to obtain specific gene fragments: 3 μl of 10×...
Embodiment 2
[0046] Using the same technical means as in Example 1, a biologically active anti-semiplasmin single-chain antibody with the transmembrane peptide KTAT was prepared, and then mixed with the dendrimer-modified cadmium telluride quantum dot solution, the reaction The conditions are: 1ml 0.85mg / ml single-chain antibody is mixed with 1ml 2.5mg / ml dendrimer-modified quantum dots (0.05M phosphate buffer, pH 7.4, 0.04% Tween-20), reacted at 4°C for 10 hours, and then , Add aminoethanol and stir the reaction at 25°C for 2h. The single-chain antibody-coated quantum dots are separated by a chromatographic column filtration method. Then, 5 μl of single-chain antibody-coated quantum dots were added to the cultured prostate cancer cell line LNCaP cell flask and the control gastric cancer cell line 7901, and they were co-cultured for 1 hour, and then washed repeatedly with phosphate buffer (pH 7.4) for 4 Again, under a fluorescent microscope, it can be seen that the prostate cancer cells h...
Embodiment 3
[0048] Using the same technical means as in Example 1, an anti-γ seminal plasma protein single-chain antibody with a transmembrane peptide KTAT was prepared, and then connected with dendrimer-modified magnetic nanoparticles to prepare an anti-γ seminal plasma protein single-chain antibody Antibody-modified magnetic nanoparticles. By injecting 200 μl of prostate cancer cell line LNCaP cells into the back of nude mice subcutaneously and feeding them for 2 weeks, tumor formation can be seen. Then, the prepared magnetic nanoparticles modified by anti-γ seminal plasma protein single-chain antibody were directly injected into the tail vein of nude mice. After 4 hours, under nuclear magnetic resonance, the magnetic nanoparticles could be seen to gather at the prostate cancer site, indicating that anti-γ Seminal protein scFv-modified magnetic nanoparticles can be used as contrast agents for prostate cancer.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com